Anixa Biosciences (ANIX): CEO bought ~$19K

~$19K

Approx. value · 7,000 sh @ $2.78

672K

Holds after · shares reported

Traded

Sep 24, 2026

Filed

Sep 28, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Sep 23, 2026Insider · First insider buy since Jul 2025Director purchased ~$132K of ANIX shares in the open market
2. Sep 24, 2026 · this disclosureInsider · 3 insiders in a week, 16th time since 2006CEO purchased ~$19K of ANIX shares in the open market

What came next

1. Sep 24, 2026Insider · 3 insiders in a week, 16th time since 2006Director purchased ~$14K of ANIX shares in the open market
2. Sep 30, 2026Insider · 3 insiders in a week, 16th time since 2006CFO purchased ~$16K of ANIX shares in the open market
3. Oct 22, 2026InsiderCEO purchased ~$22K of ANIX shares in the open market
4. Oct 23, 2026InsiderDirector purchased ~$24K of ANIX shares in the open market
5. Oct 30, 2026InsiderCEO purchased ~$16K of ANIX shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Anixa Biosciences

For Anixa Biosciences, OQRO holds 7 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ANIX page.

Other recent filings by Amit Kumar, Chief Executive Officer

• SEC Form 4 at Anixa Biosciences (ANIX)Nov 2, 2026
• SEC Form 4 at Anixa Biosciences (ANIX)Oct 22, 2026
• SEC Form 4 at Anixa Biosciences (ANIX)Jul 31, 2025
• SEC Form 4 at Anixa Biosciences (ANIX)Jul 14, 2025
• SEC Form 4 at Anixa Biosciences (ANIX)Jun 5, 2025

The full history of Amit Kumar, Chief Executive Officer is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Anixa Biosciences

• SEC Form 4Nov 2, 2026
• SEC Form 4Oct 26, 2026
• SEC Form 4Oct 22, 2026
• SEC Form 4Sep 30, 2026
• SEC Form 4Sep 28, 2026
• SEC Form 4Sep 25, 2026

Everything OQRO holds on this company is on its ANIX page.